Insider · CIK 0002146784
Annita Tanini
Files at KROS (Keros Therapeutics, Inc.). First filing Aug 20, 2026, latest Aug 20, 2026.
In brief
Annita Tanini files SEC Form 4 as officer at KROS (Keros Therapeutics, Inc.). Since Aug 20, 2026, Annita Tanini has reported 0 open-market buys worth $0 and 1 open-market sell worth $13k, the latest filed on Aug 20, 2026.
A track record needs three past buys with six months of prices behind them; Annita Tanini has 0, so none is measured yet.
The newest scored trade: sold $13k of KROS on Aug 18, 2026, filed Aug 20, 2026, scored 30 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $13k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KROS: Keros Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Keros Therapeutics, Inc. | $13k 1,224 shares | -3% | +7% from low-51% from high |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | KROS Keros Therapeutics, Inc. | SOpen-market sale Common Stock | -1,224 | $10.29 | $13k | 45,144 | Aug 20, 2026 |
Questions about Annita Tanini
Answered from the filings on this page, as of the latest one.
Is Annita Tanini buying or selling?
In the last 12 months Annita Tanini reported 0 open-market buys worth $0 and 1 open-market sell worth $13k on SEC Form 4; the latest was sold $13k of KROS on Aug 18, 2026. Grants, option exercises and tax withholding are not counted.
How did Annita Tanini's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Annita Tanini has 0.
Where does Annita Tanini file Form 4?
Annita Tanini has filed Form 4 at KROS (Keros Therapeutics, Inc.) as Corp. Controller & VP, Finance. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.